Clinical Evaluation of the efficiency of allogeneic cord blood transfusion in patients with autism
- Authors: Tyumina O.V1,2, Volchkov S.E1, Ovchinnikov P.A1, Trusova L.M1, Bugakov A.I1, Romanova S.A3, Bumagina L.V3, Galahova O.O3
-
Affiliations:
- Samara Regional Medical Center Dynasty
- Samara Medical University
- N.N. Ivanova Samara Regional Children's Clinical Hospital
- Issue: Vol 15, No 3 (2020)
- Pages: 74-79
- Section: Articles
- URL: https://genescells.ru/2313-1829/article/view/121998
- DOI: https://doi.org/10.23868/202011012
- ID: 121998
Cite item
Abstract
Keywords
Full Text

About the authors
O. V Tyumina
Samara Regional Medical Center Dynasty; Samara Medical University
S. E Volchkov
Samara Regional Medical Center Dynasty
P. A Ovchinnikov
Samara Regional Medical Center Dynasty
L. M Trusova
Samara Regional Medical Center Dynasty
A. I Bugakov
Samara Regional Medical Center Dynasty
S. A Romanova
N.N. Ivanova Samara Regional Children's Clinical Hospital
L. V Bumagina
N.N. Ivanova Samara Regional Children's Clinical Hospital
O. O Galahova
N.N. Ivanova Samara Regional Children's Clinical Hospital
References
- Информационные бюллетени. Расстройства аутистического спектра (РАС): сайт ВОЗ. [Электронный ресурс]. 2020. Дата обновления: 07.11.2019. URL:https://www.who.int/ru/news-room/fact-sheets/ detail/autism-spectrum-disorders (дата обращения: 10.03.2020)
- Onore C., Careaga M., Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav. Immun. 2012; 26(3): 383-92
- Ashwood P., Corbett B.A., Kantor A. et al. In search of cellular immuno-phenotypes in the blood of children with autism. PLoS One 2011; 6(5): e19299.
- Enstrom A.M., Lit L., Onore C.E. et al. Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav. Immun. 2009; 23(1): 124-33.
- Masi A., DeMayo M.M., Glozier N. et al. An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options. Neurosci. Bull. 2017; 33(2): 183-93.
- Siniscalco D., Antonucci N. Cellular therapy for autism spectrum disorder: a step forward to the optimal treatments. Ann. Transl. Med. 2019; 7 Suppl 3: S110.
- Park D.H., Borlongan C.V., Willing A.E. et al. Human umbilical cord blood cell grafts for brain ischemia. Cell Transplant. 2009; 18(9): 985-98.
- Wilcox J., Tsuang M.T., Ledger E. et al. Brain perfusion in autism varies with age. Neuropsychobiology 2002; 46(1): 13-6.
- Dawson G., Sun J.M., Davlantis K.S. et al. Autologous Cord Blood Infusions Are Safe and Feasible in Young Children with Autism Spectrum Disorder: Results of a Single-Center Phase I Open-Label Trial. Stem Cells Transl. Med. 2017; 6(5): 1332-9.
- Frye R.E. Behaviorally associated changes in neuroconnectivity following autologous umbilical cord blood infusion in young children with autism spectrum disorder. Ann. Transl. Med. 2019; 7 Suppl 3: S123.
- Chez M., Lepage C., Parise C. et al. Safety and observations from a placebo-controlled, crossover study to assess use of autologous umbilical cord blood stem cells to improve symptoms in children with autism. Stem Cells Transl. Med. 2018; 7(4): 333-41.
